Orthopedic Devices - D-A-CH

  • D-A-CH
  • The Orthopedic Devices market market in D-A-CH, which includes Germany, Austria, and Switzerland, is forecasted to achieve a revenue of US$4.00bn in 2024.
  • This market is expected to exhibit a compound annual growth rate (CAGR) of 3.32% between 2024 and 2029, leading to a market volume of US$4.71bn by 2029.
  • Comparatively, the United States will generate the highest revenue in the global market, amounting to US$16,020.00m in 2024.
  • Germany is leading the way in the orthopedic devices market with its advanced research and development capabilities.

Key regions: France, Netherlands, Europe, Germany, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Orthopedic Devices market in D-A-CH, which includes Germany, Austria, and Switzerland, is experiencing steady growth driven by several factors.

Customer preferences:
Customers in the D-A-CH region have a strong preference for high-quality orthopedic devices that offer advanced technology and innovative features. They prioritize devices that provide effective treatment options and improve the quality of life for patients. Additionally, customers in this region value personalized healthcare solutions and are willing to invest in orthopedic devices that are tailored to their specific needs.

Trends in the market:
One of the key trends in the Orthopedic Devices market in D-A-CH is the increasing demand for minimally invasive procedures. Patients are seeking less invasive treatment options that offer faster recovery times and reduced post-operative pain. This trend is driving the adoption of orthopedic devices such as arthroscopy instruments and robotic-assisted surgical systems, which enable surgeons to perform procedures with greater precision and minimal disruption to the surrounding tissues. Another significant trend in the market is the growing prevalence of orthopedic conditions, such as osteoarthritis and osteoporosis, among the aging population. As the population in D-A-CH continues to age, the demand for orthopedic devices, including joint replacement implants and bone graft substitutes, is expected to increase. Additionally, the rising incidence of sports-related injuries is fueling the demand for orthopedic devices such as braces, supports, and orthotics.

Local special circumstances:
Germany, Austria, and Switzerland have well-developed healthcare systems that prioritize patient care and safety. The reimbursement policies in these countries ensure that patients have access to a wide range of orthopedic devices, including both surgical and non-surgical options. Furthermore, the presence of leading orthopedic device manufacturers in the region, along with strong research and development capabilities, contributes to the availability of innovative products.

Underlying macroeconomic factors:
The strong economic growth in the D-A-CH region, coupled with the increasing healthcare expenditure, is driving the growth of the Orthopedic Devices market. The favorable reimbursement policies and the high level of healthcare infrastructure and facilities support the adoption of advanced orthopedic devices. Additionally, the region's well-established medical device regulations and standards ensure the safety and efficacy of orthopedic devices, which further boosts customer confidence and market growth. In conclusion, the Orthopedic Devices market in D-A-CH is witnessing steady growth driven by customer preferences for high-quality devices, the increasing demand for minimally invasive procedures, and the growing prevalence of orthopedic conditions. The region's well-developed healthcare systems, favorable reimbursement policies, and strong economic growth contribute to the market's positive trajectory.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)